IDEAYA Biosciences Inc (NASDAQ:IDYA)
| 30.88 BATS BZX Real-Time Price As of 2:01pm ET |  -0.53 / -1.69%Today’s Change | 13.29 Today|||52-Week Range 33.24 | +69.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Operating Activities | Net Income / Starting Line | -11.9M | -34.3M | -- | -- | |
| Depreciation | 391.0K | 886.0K | -- | -- | ||
| Total Other Cash Flow | -2.3M | 4.2M | -- | -- | ||
| Funds From Operations | -13.8M | -29.3M | -- | -- | ||
| Funds From/For Other Operating Expenses | -1.6M | -1.7M | -- | -- | ||
| Net Cash Flow - Operating Activities | -12.2M | -27.6M | -- | -- | ||
| Investing | Increase In Investments | -13.5M | -133.3M | -- | -- | |
| Decrease In Investments | 6.3M | 71.8M | -- | -- | ||
| Capital Expenditures | -1.8M | -1.7M | -- | -- | ||
| Net Cash Flow Investing | -8.9M | -63.2M | -- | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -- | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | -- | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | -- | -- | -- | |
| Net Proceeds Stock Sale | 17.5M | 105.4M | -- | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -- | -- | -- | |
| Common Dividends | 0.00 | 0.00 | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | -- | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | -- | -- | -- | |
| Net Cash Flow - Financing | 17.5M | 105.4M | -- | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -3.7M | 14.6M | -- | -- | ||
